Selegiline and cognitive function in Parkinson's disease.

作者: M. H. Hietanen

DOI: 10.1111/J.1600-0404.1991.TB04978.X

关键词: Cognitive flexibilityAudiologyPsychologySelegilineNeuropsychologyCognitionPlaceboLevodopaCognitive disorderPsychiatryParkinson's disease

摘要: Eighteen patients with Parkinson's disease were treated placebo for 4 weeks and the MAO-B inhibitor selegiline 8 without levodopa in a randomized double-blind clinical study. The maximum dose of was 30 mg/day patients' cognitive functions evaluated before treatment at week 12 when they either on mg or placebo. A series neuropsychological tests used to study general reasoning, memory, visuospatial abilities, attention, flexibility, motor depression. Specific effects not observed. Slight improvement occurred mainly learning (easy word associations) which may reflect limited, nonspecific arousal effect.

参考文章(21)
A. J. Lees, J. Frankel, V. Eatough, G. M. Stern, New approaches in the use of selegiline for the treatment of Parkinson's disease. Acta Neurologica Scandinavica. ,vol. 80, pp. 139- 145 ,(1989) , 10.1111/J.1600-0404.1989.TB01793.X
GP Reynolds, JD Elsworth, K Blau, M Sandler, AJ Lees, GM Stern, Deprenyl is metabolized to methamphetamine and amphetamine in man. British Journal of Clinical Pharmacology. ,vol. 6, pp. 542- 544 ,(1978) , 10.1111/J.1365-2125.1978.TB00883.X
Graham Ratcliff, Spatial thought, mental rotation and the right cerebral hemisphere. Neuropsychologia. ,vol. 17, pp. 49- 54 ,(1979) , 10.1016/0028-3932(79)90021-6
B. Djahanguiri, S. Hemmati, D. Sadeghi, A. Firouzabadi, The prevention of acute gastric ulcer in the rat by alpha-methyldopa. Medicina et pharmacologia experimentalis. International journal of experimental medicine. ,vol. 17, pp. 427- 433 ,(1967) , 10.1159/000137111
David Wechsler, A Standardized Memory Scale for Clinical Use The Journal of Psychology. ,vol. 19, pp. 87- 95 ,(1945) , 10.1080/00223980.1945.9917223
Pierre N. Tariot, L-Deprenyl in Alzheimer's Disease Archives of General Psychiatry. ,vol. 44, pp. 427- 433 ,(1987) , 10.1001/ARCHPSYC.1987.01800170041007
David Wechsler, Manual for the Wechsler Adult Intelligence Scale. Psychological Corp.. ,(1955)
M. M. Hoehn, M. D. Yahr, Parkinsonism: Onset, progression, and mortality Neurology. ,vol. 17, pp. 427- 442 ,(1967) , 10.1212/WNL.17.5.427
P.N. Tariot, T. Sunderland, H. Weingartner, D.L. Murphy, J.A. Welkowitz, K. Thompson, R.M. Cohen, Cognitive effects of L-deprenyl in Alzheimer's disease. Psychopharmacology. ,vol. 91, pp. 489- 495 ,(1987) , 10.1007/BF00216016
J. Mendlewicz, M. B. H. Youdim, L-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluation. British Journal of Psychiatry. ,vol. 142, pp. 508- 511 ,(1983) , 10.1192/BJP.142.5.508